Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss

Area of Science:

• Otolaryngology
• Cell Biology
• Genetics

Background:

• Reactive oxygen species (ROS) from NADPH oxidases (Nox) are implicated in sensorineural hearing loss (SNHL).
• Previous studies on Nox3's role in hearing and its expression in the inner ear yielded ambiguous results.
• Understanding Nox3's precise role is crucial for developing SNHL treatments.

Purpose of the Study:

• To investigate the expression patterns of Nox3 in the inner ear using a novel reporter mouse model.
• To determine the specific cell types and regions in the cochlea where Nox3 is expressed.
• To elucidate the role of Nox3 in different types of SNHL, including cisplatin-induced, age-related, and noise-induced hearing loss.

Main Methods:

• Generation of Nox3-Cre knock-in mice and Nox3-Cre;tdTomato reporter mice.
• Immunohistological analysis to identify Nox3-expressing cells in the inner ear.
• Assessment of Nox3 expression levels under various insults (cisplatin, aging, noise).

Main Results:

• Nox3 is expressed in various cochlear cells, including supporting cells, outer hair cells, inner hair cells, and spiral ganglion neurons.
• Nox3 expression significantly increases in response to cisplatin, aging, and noise exposure.
• Increased Nox3 expression, particularly in basal turn cochlear cells, is essential for ROS-related SNHL and leads to outer hair cell apoptosis.

Conclusions:

• Nox3 is a key mediator of ROS-related SNHL in response to various insults.
• The Nox3-Cre;tdTomato reporter system effectively visualizes Nox3 expression in the inner ear.
• Targeting Nox3 in the cochlea presents a promising therapeutic avenue for preventing and treating SNHL.